| 2008 | DISTRIBUTION AND METABOLISM OF NEW ALK-5 INHIBITOR, IN-1130 | 신윤용; 김대기 | Meeting Abstract |
| 2012 | Synthesis and biological evaluation of 2-benzylamino-4(5)-(6-methylpyridin- 2-yl)-5(4)-([1,2,4]triazolo[1,5-a]-pyridin-6-yl)thiazoles as transforming growth factor-β type 1 receptor kinase inhibitors | 신윤용; 김대기; 김승원 | Article |
| 2008 | Pharmacokinetics and tissue distribution of 3-((5-(6-methylpyridin-2-yl)-4- (quinoxalin-6-yl)-1H-imidazol-2-yl)methyl)benzamide; a novel ALK5 inhibitor and a potential anti-fibrosis drug | 신윤용; 이화정; 김대기 | Article |
| 2004 | Antiproliferative effect of trichostatin A and HC-toxin in T47D human breast cancer cells | 신윤용; 김대기 | Article |
| 2004 | HDAC inhibitor stimulate CYP3A4 proximal activity in Hepa I and HepG2 cells | 신윤용; 김대기 | Meeting Abstract |
| 2014 | 4-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-5(3)-(6-methylpyridin-2-yl)imidazole and -pyrazole derivatives as potent and selective inhibitors of transforming growth factor-β type i receptor kinase | 신윤용; 김대기 | Article |
| 2012 | Anti-cancer effect of IN-2001 in MDA-MB-231 human breast cancer | 신윤용; 김대기 | Article |
| 2012 | Anti-cancer effect of in-2001 in T47D human breast cancer | 신윤용; 김대기 | Article |
| 2014 | An novel inhibitor of TGF-β type I receptor, IN-1130, blocks breast cancer lung metastasis through inhibition of epithelial-mesenchymal transition | 신윤용; 김대기 | Article |
| 2014 | Discovery of N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin- 2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline (EW-7197): A highly potent, selective, and orally bioavailable inhibitor of TGF-β type I receptor kinase as cancer immunotherapeutic/antifibrotic agent | 신윤용; 이화정; 김대기 | Article |
